Abstract

Endothelial dysfunction, or activation, elicited by oxidized low density lipoprotein (Ox-LDL) or its lipid constituent, has been implicated in the initiation and progression of atherosclerosis. We have recently identified a C-type lectin-like molecule, designated lectin-like Ox-LDL receptor-1 (LOX-1), which acts as a cell-surface receptor for Ox-LDL in cultured vascular endothelial cells. In this report, we provide evidence that LOX-1 expression can be upregulated by tumor necrosis factor -α (TNF-α) and phorbol myristate acetate (PMA) in cultured bovine aortic endothelial cells. TNF-α and PMA upregulated LOX-1 protein and mRNA expression in a time- and dose-dependent manner. Nuclear run-off assay revealed TNF-α and fluid shear stress stimulates transcription of LOX-1 gene. CHO-K1 cells stably expressing LOX-1 internalized Dil-labeled Ox-LDL but not significantly acetylated LDL (Ac-LDL), which was effectively suppressed by excess amounts of unlabeled Ox-LDL but not by Ac-LDL. Upregulated expression of LOX-1 by TNF-a and PMA was associated with increased uptake of Dil-Ox-LDL that can not be blocked by excess amounts of unlabeled Ac-LDL. LOX-1 expression was also detectable in human peripheral blood monocytes after macrophage-like differentiation in vitro, the moncytic cell line THP-1 cells after macrophage-like differentiation by PMA, and murine peritoneal macrophages. Taken together, LOX-1 is a receptor specific for Ox-LDL, and enhanced uptake of Ox-LDL via this novel receptor on vascular endothelial cells and macrophages may play important roles in both endothelial activation and foam cell transformation of macrophages in atherogenesis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call